RandyW Posted December 28, 2006 Share Posted December 28, 2006 Adventrx gets green light Adventrx Pharmaceuticals said the Food and Drug Administration accepted its application to begin testing a potential cancer drug. The San Diego drug development company said it would conduct clinical trials to establish that its drug, ANX-530, works the same as Navelbine, an anti-cancer agent approved to fight non-small-cell lung cancer. Adventrx will begin testing the drug in humans in January. The company said it expected to file an application seeking approval for the drug by the end of 2007. Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.